June 12, 2020 / 11:34 AM / a month ago

BRIEF-Esperion Confirms NEXLETOL Tablets To Be Included In Assessment Of Non-Statin Medicines For Hypercholesterolemia By ICER

June 12 (Reuters) - Esperion Therapeutics Inc:

* ESPERION CONFIRMS NEXLETOL™ (BEMPEDOIC ACID) TABLETS TO BE INCLUDED IN ASSESSMENT OF NON-STATIN MEDICINES FOR HYPERCHOLESTEROLEMIA BY ICER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below